Estabelished in 2007 , Hunan Ouya Pharmaceutical Co., Ltd is located in Liuyang Economic and Technological Development Zone. The main business includes API and intermediate sector and CDMO sector with two production site and three R&D center. For the API we focus on the Small molecule compound for cardiovascular. For the CDMO We are building the strength for the reaction of asymmetric synthesis, grignardreaction, oxidation-reduction and ahwater -free reaction. We also provide the service for compound and API developing and manufacturing.
more >
Year of Establishment:
2007
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Own GMP in some APIs' products;
Mass production in workshop;
Serious to control the quality of product;
Best quality and High speed feedback of Customers Service.
Patents and Copyrights:
Patents:
Biapenem Intermediates
preparation method of 6,7-Dihydro-6-mercapto-5H-pyrazolo[1,2-a][1,2,4]triazolium chloridePreparation method of Cefoselis Hydrogen Sulfate
The industrial capability of prulifloxacin
Business Type:
Manufacturer,Trading Company
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Own GMP in some APIs' products;
Mass production in workshop;
Serious to control the quality of product;
Best quality and High speed feedback of Customers Service.
Patents and Copyrights:
Patents:
Biapenem Intermediates
preparation method of 6,7-Dihydro-6-mercapto-5H-pyrazolo[1,2-a][1,2,4]triazolium chloridePreparation method of Cefoselis Hydrogen Sulfate
The industrial capability of prulifloxacin